Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The Afferent Visual Pathway: Designing a Structural-Functional Paradigm of Multiple Sclerosis.
The pill times 2: What every woman with multiple sclerosis should know.
Targeting the shift from m1 to m2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudil.
Natural, innate improvements in multiple sclerosis disability.
Intrauterine environment and multiple sclerosis: a population- based case-control study.
A population based cohort study to assess the safety of pandemic influenza vaccine Focetria(®) in Emilia-Romagna region, Italy-Part Two.
The role of regulatory T cells in neurodegenerative diseases.
[Prevention of multiple sclerosis: A realistic goal?]
Multiple sclerosis reactivation postfingolimod cessation: Is it IRIS?
Rebif Advanced Magnetic Resonance Imaging (MRI) and Immunology Pilot Trial
IFN-γ ameliorates autoimmune encephalomyelitis by limiting myelin lipid peroxidation.
Treatment of HIV and Risk of Multiple Sclerosis.
Pathophysiology of the brain extracellular matrix: a new target for remyelination.
Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?
Neurofilaments as biomarkers in multiple sclerosis.
Lysoglycerophospholipids in chronic inflammatory disorders: The PLA(2)/LPC and ATX/LPA axes.
Evidence that nuclear factor IA inhibits repair after white matter injury.
[American Academy of Neurology, Washington, 18-25 April 2015].
JCV test stratifies PML risk in antibody-positive MS
Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
MARINOL®
Transplantation of Human Adipose-Derived Stem Cells Enhances Remyelination in Lysolecithin-Induced Focal Demyelination of Rat Spinal Cord.
Peripheral blood T cell dynamics predict relapse in multiple sclerosis patients on fingolimod.
Natalizumab modulates the humoral response against HERV-Wenv73-88 in a follow-up study of Multiple Sclerosis patients.

Pages